2026-11-10 22:52:00 UTC#612325newconfirmednews
Morgan Stanley (MS) stock news
Morgan Stanley (MS) stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-11-10 20:20:05 UTC#611200duplicateconfirmednews
Morgan Stanley reiterates view that Argentina sovereign debt selloff is overdone
2026-11-10 17:35:00 UTC#610294newconfirmednews
Morgan Stanley maintains Via Transportation at Overweight, raises price target to $48 from $33
2026-11-10 17:29:00 UTC#610260newconfirmednews
Morgan Stanley maintains Somnigroup International at Overweight, cuts price target to $90 from $95
2026-11-10 17:23:44 UTC#610205newconfirmednews
Morgan Stanley maintains Unum Group at Equal-Weight, lowers price target to $85 from $92
2026-11-10 17:22:56 UTC#610209newconfirmednews
Morgan Stanley maintains TWFG at Overweight, raises price target to $31 from $30
2026-11-10 17:21:49 UTC#610219newconfirmednews
Morgan Stanley maintains The Trade Desk at Equal-Weight, raises price target to $14 from $13
2026-11-10 17:21:02 UTC#610222newconfirmednews
Morgan Stanley maintains TeraWulf at Overweight, cuts price target to $47 from $65
2026-11-10 17:21:00 UTC#610225newconfirmednews
Morgan Stanley maintains MPLX at Equal-Weight, cuts price target to $60 from $64
2026-11-10 17:17:00 UTC#610167newconfirmednews
Morgan Stanley maintains LPL Financial Holdings at Overweight, raises price target to $399 from $393
2026-11-10 17:16:00 UTC#610176newconfirmednews
Morgan Stanley maintains Kinetik Holdings at Overweight, cuts price target to $64 from $67
2026-11-10 17:16:00 UTC#610172newconfirmednews
Morgan Stanley maintains KKR & Co. at Overweight, raises price target to $140 from $138
2026-11-10 17:15:44 UTC#610181newconfirmednews
Morgan Stanley maintains Qualys at Underweight, raises price target to $140 from $130
2026-11-10 17:14:44 UTC#610194newconfirmednews
Morgan Stanley maintains Onto Innovation at Overweight, cuts price target to $325 from $360
2026-11-10 17:02:55 UTC#610050newconfirmednews
Morgan Stanley maintains e.l.f. Beauty at Equal-Weight, raises price target to $125 from $103
2026-11-10 17:02:06 UTC#610058newconfirmednews
Morgan Stanley maintains Criteo at Equal-Weight, lowers price target to $20 from $25
2026-11-10 17:01:05 UTC#610069newconfirmednews
Morgan Stanley maintains Bicara Therapeutics at Overweight, cuts price target to $30 from $41
2026-11-10 17:00:18 UTC#610081newconfirmednews
Morgan Stanley maintains Attovia Therapeutics at Overweight, raises price target to $40 from $39
2026-11-10 16:58:50 UTC#610160newconfirmednews
Morgan Stanley maintains Antero Midstream at Equal-Weight, lowers price target to $24 from $26
2026-11-10 16:53:27 UTC#610012newconfirmedanalysis